Cargando…

Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features

BACKGROUND: This study aims to examine the influence of human transformer-2-beta1 (Tra2-beta1) on endometrial carcinoma (EC) development. The effects of Tra2-beta1 on the proliferation, apoptosis, invasion, and cell cycle of EC cells were also investigated. METHODS: Functional in vitro experiments w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wenhuizi, Paudel, Dhruba, Song, Sirui, Chen, Kewei, Zhao, Zhanqi, Chu, Lei, Ouyang, Yiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797671/
https://www.ncbi.nlm.nih.gov/pubmed/35117625
http://dx.doi.org/10.21037/tcr.2020.02.66
_version_ 1784641607620886528
author Sun, Wenhuizi
Paudel, Dhruba
Song, Sirui
Chen, Kewei
Zhao, Zhanqi
Chu, Lei
Ouyang, Yiqin
author_facet Sun, Wenhuizi
Paudel, Dhruba
Song, Sirui
Chen, Kewei
Zhao, Zhanqi
Chu, Lei
Ouyang, Yiqin
author_sort Sun, Wenhuizi
collection PubMed
description BACKGROUND: This study aims to examine the influence of human transformer-2-beta1 (Tra2-beta1) on endometrial carcinoma (EC) development. The effects of Tra2-beta1 on the proliferation, apoptosis, invasion, and cell cycle of EC cells were also investigated. METHODS: Functional in vitro experiments were performed on Tra2-beta1 knockdown cells and hypoxic model cells. Western blot was used to detect HIF-1a, vascular endothelial growth factor (VEGF), and Tra2-beta1 protein expression; CCK8 assay was used to detect cell proliferation; flow cytometry was used to detect apoptosis and cell cycle, and Transwell assay was used to detect cell invasion ability. Tumor specimens were collected from 128 consecutive patients to detect the expression of Tra2-beta1, and the relationship between and EC and Tra-beta1 were analyzed by clinical pathological data, which included lymph node metastasis, pathological types, histological grade, myometrial invasion, etc. RESULTS: Tra2-beta1 was highly expressed in EC and was associated with clinical pathological features. It was related to the prognosis, and was found to promote proliferation (F=48.3, P<0.001) and migration (P<0.05), and inhibit apoptosis (P<0.05). Statistical analyses revealed a positive correlation between Tra2-beta1 and HIF-1a (correlation coefficient =0.36, P<0.001) and VEGF protein (correlation coefficient =0.23, P=0.021). In the hypoxic cell group and the combined intervention group, cell proliferation after 72 h was 9,783±45.6 and 6,783±68.4 (P<0.001), while the number of invasive cells was 421±16.8 and 276±11.2 (P<0.001), respectively. The apoptosis rates were 0.45±0.03 and 1.28±0.16, respectively (P<0.05). CONCLUSIONS: The present findings demonstrate that the development of EC is positively correlated with Tra2-beta1. Tra2-beta1 may reverse the effect of hypoxia on EC, and this may provide new insights into the occurrence and development of EC.
format Online
Article
Text
id pubmed-8797671
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87976712022-02-02 Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features Sun, Wenhuizi Paudel, Dhruba Song, Sirui Chen, Kewei Zhao, Zhanqi Chu, Lei Ouyang, Yiqin Transl Cancer Res Original Article BACKGROUND: This study aims to examine the influence of human transformer-2-beta1 (Tra2-beta1) on endometrial carcinoma (EC) development. The effects of Tra2-beta1 on the proliferation, apoptosis, invasion, and cell cycle of EC cells were also investigated. METHODS: Functional in vitro experiments were performed on Tra2-beta1 knockdown cells and hypoxic model cells. Western blot was used to detect HIF-1a, vascular endothelial growth factor (VEGF), and Tra2-beta1 protein expression; CCK8 assay was used to detect cell proliferation; flow cytometry was used to detect apoptosis and cell cycle, and Transwell assay was used to detect cell invasion ability. Tumor specimens were collected from 128 consecutive patients to detect the expression of Tra2-beta1, and the relationship between and EC and Tra-beta1 were analyzed by clinical pathological data, which included lymph node metastasis, pathological types, histological grade, myometrial invasion, etc. RESULTS: Tra2-beta1 was highly expressed in EC and was associated with clinical pathological features. It was related to the prognosis, and was found to promote proliferation (F=48.3, P<0.001) and migration (P<0.05), and inhibit apoptosis (P<0.05). Statistical analyses revealed a positive correlation between Tra2-beta1 and HIF-1a (correlation coefficient =0.36, P<0.001) and VEGF protein (correlation coefficient =0.23, P=0.021). In the hypoxic cell group and the combined intervention group, cell proliferation after 72 h was 9,783±45.6 and 6,783±68.4 (P<0.001), while the number of invasive cells was 421±16.8 and 276±11.2 (P<0.001), respectively. The apoptosis rates were 0.45±0.03 and 1.28±0.16, respectively (P<0.05). CONCLUSIONS: The present findings demonstrate that the development of EC is positively correlated with Tra2-beta1. Tra2-beta1 may reverse the effect of hypoxia on EC, and this may provide new insights into the occurrence and development of EC. AME Publishing Company 2020-04 /pmc/articles/PMC8797671/ /pubmed/35117625 http://dx.doi.org/10.21037/tcr.2020.02.66 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Sun, Wenhuizi
Paudel, Dhruba
Song, Sirui
Chen, Kewei
Zhao, Zhanqi
Chu, Lei
Ouyang, Yiqin
Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features
title Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features
title_full Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features
title_fullStr Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features
title_full_unstemmed Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features
title_short Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features
title_sort effects of tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797671/
https://www.ncbi.nlm.nih.gov/pubmed/35117625
http://dx.doi.org/10.21037/tcr.2020.02.66
work_keys_str_mv AT sunwenhuizi effectsoftra2beta1onproliferationapoptosisandmetastasisofhypoxicendometrialcarcinomacellanditscorrelationwithclinicopathologicalfeatures
AT paudeldhruba effectsoftra2beta1onproliferationapoptosisandmetastasisofhypoxicendometrialcarcinomacellanditscorrelationwithclinicopathologicalfeatures
AT songsirui effectsoftra2beta1onproliferationapoptosisandmetastasisofhypoxicendometrialcarcinomacellanditscorrelationwithclinicopathologicalfeatures
AT chenkewei effectsoftra2beta1onproliferationapoptosisandmetastasisofhypoxicendometrialcarcinomacellanditscorrelationwithclinicopathologicalfeatures
AT zhaozhanqi effectsoftra2beta1onproliferationapoptosisandmetastasisofhypoxicendometrialcarcinomacellanditscorrelationwithclinicopathologicalfeatures
AT chulei effectsoftra2beta1onproliferationapoptosisandmetastasisofhypoxicendometrialcarcinomacellanditscorrelationwithclinicopathologicalfeatures
AT ouyangyiqin effectsoftra2beta1onproliferationapoptosisandmetastasisofhypoxicendometrialcarcinomacellanditscorrelationwithclinicopathologicalfeatures